Astera Labs vs. Arm: Which AI-Driven Tech Stock Is a Better Buy in 2026?

As the artificial intelligence buildout enters its next phase, investors are weighing the explosive growth of Astera Labs (NASDAQ:ALAB) against the massive scale of Arm (NASDAQ:ARM) to find the best buy.

Astera Labs provides the critical hardware links that allow AI chips to communicate, while Arm provides the underlying architectural blueprints used to design those chips. Both companies sit at the heart of modern computing.

The case for Astera Labs

Astera Labs designs and sells semiconductor-based connectivity solutions that help hyperscalers and AI accelerator vendors manage massive data flows. Its product line includes PCIe and CXL technologies that serve as the plumbing for modern semiconductor stocks in data center environments. Customer concentration like this adds a layer of risk to the business, as one end customer accounted for over 70% of revenue in 2025.

In the fiscal year ended Dec. 31, 2025, revenue reached nearly $852.5 million, representing a 115.1% increase compared with the prior fiscal year. The company also shifted to profitability, reporting net income of approximately $219.1 million after recording a net loss in 2024. This growth was largely driven by the rapid expansion of AI infrastructure as cloud providers raced to build out new server racks.

As of its December 2025 balance sheet, the current ratio is 10.2x, which indicates a strong ability to cover short-term obligations with current assets. The debt-to-equity ratio is 0.0x, showing the company uses no debt relative to its shareholder equity. Free cash flow for the fiscal year ended Dec. 31, 2025, was roughly $281.8 million. Note that stock-based compensation represented roughly 50.1% of operating cash flow, which inflates reported cash generation since SBC is a non-cash expense added back in the cash flow statement.

The case for Arm

Arm operates a highly efficient business model by licensing its CPU and compute-platform designs to virtually every major chipmaker in the world. Instead of manufacturing its own hardware, the company earns royalties and licensing fees every time a chip using its architecture is sold. This gives Arm a presence in everything from smartphones and consumer electronics to the world's most powerful supercomputers and cloud servers.

In the fiscal year ended March 31, 2026, revenue reached close to $4.9 billion, a 22.8% increase year over year. Net income for the same period was approximately $904.0 million, reflecting a net margin of 18.4%. While its growth is slower than that of smaller rivals, Arm benefits from a massive installed base that makes its architecture a standard across the tech industry.

As of its March 2026 balance sheet, the debt-to-equity ratio is approximately 0.1x, which indicates a very conservative amount of debt compared with shareholder equity. The current ratio is 6.0x, providing a substantial cushion for meeting short-term financial commitments. Free cash flow for the fiscal year ended March 31, 2026, was nearly $979.0 million. Note that stock-based compensation represented roughly 69% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.

Risk profile comparison

Astera Labs faces significant risks due to its heavy reliance on a few massive customers, with its top three clients representing roughly 86% of total revenue. The company also faces intense competition from established giants like Broadcom (NASDAQ:AVGO), Marvell Technology (NASDAQ:MRVL), and Rambus (NASDAQ:RMBS). Furthermore, its fabless model makes it dependent on a single fabricator, which could lead to supply chain disruptions if geopolitical tensions rise in East Asia.

Arm faces risks related to the potential shift toward open-source architectures like RISC-V, which could threaten its licensing dominance over time. The company also maintains a significant concentration in the mobile market, which can be cyclical and unpredictable. Because much of its growth depends on the continued adoption of higher-royalty architectures, any slowdown in the data center or automotive sectors could impact its future revenue targets.

Valuation comparison

Astera Labs appears cheaper based on its future earnings estimates, and also offers a slightly lower price relative to its annual sales.

Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.

Which stock would I buy in 2026?

I'd go with Astera Labs. The company has strung together one of the most impressive growth streaks in the semiconductor industry, with revenue expanding at a pace approaching or exceeding triple digits for several consecutive quarters. Its connectivity chips and optical products are becoming essential inside the AI data centers being built by every major hyperscaler. Gross margins are tracking well above 70%, and management guided for more than 85% revenue growth for the full year.

Arm has its strengths. Its chip architecture powers virtually every smartphone and is rapidly expanding into AI data centers, with royalty revenue more than doubling in that segment. The smartphone business still anchors roughly half of royalty revenue, which gives it a reliable foundation that cushions the cyclicality of the AI infrastructure build. For investors who value durability and consistency, it is a strong choice.

But Arm's growth, while impressive, is more measured than Astera's. Customer concentration is a risk worth watching, but the demand behind those relationships keeps accelerating. Owning a company growing this fast with margins this strong, at this stage of the AI infrastructure build-out, could be incredibly rewarding. Just make sure you can stomach some volatility along the way.

Sara Appino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Arm Holdings, Broadcom, and Marvell Technology. The Motley Fool recommends Astera Labs. The Motley Fool has a disclosure policy.